John Reilly

Critical Care Doc, Epidemiologist, ARDS & Sepsis Researcher. Living in Philly (Northern Liberties). 🏳️‍🌈 He/Him/His. Views my own.

[ATS Crit Care @ATSCritCare]

John Reilly kicks off the session on precision ARDS with Identifying Treatable Traits and Examining Heterogeneity of Treatment Effect in Critical Care Trials

#ats2025 #ATSCritCareLive 

@ATS_Assemblies @atscommunity

[Hayley Gershengorn @HBGMD]

📣 #journal_CHESTCritCare, volume 3, issue 1 has landed 🛬

https://t.co/hfSGW7nZuK

👀 Check out the:
⭐️ 3 editorials
⭐️ 14 original research / research letters
⭐️ 2 CHEST CC reviews
⭐️ 2 How I Do Its

All #OpenAccess, all the time.

[nature @Nature]

In an unprecedented move, the US National Institutes of Health has begun mass terminations of research grants that fund active scientific projects because they no longer meet “agency priorities”.

https://t.co/ALQlFtfuVd

[Snigdha Jain MD, MHS @snigdhajain89]

Hangjng out with the superfun #journal_ChestCritCare crew!

@journal_CHEST
@HBGMD @John_P_Reilly @ErinCarlton

[Timothy Snyder @TimothyDSnyder]

Do not obey in advance. Lesson 1, first page, of my pamphlet "On Tyranny"

[Hayley Gershengorn @HBGMD]

🤰Views differ, but many worry new laws in the US may ⬆️ pregnant/post-partum patients in our ICUs…

So, it’s timely that Kolbe, @DesertFox1976, et al evaluate lactation practices 🍼 in ICU…

https://t.co/Nu5NcWdLAb

🛑 Spoiler alert — we could do better

#journal_CHESTCritCare

[John Reilly @John_P_Reilly]

https://t.co/I5FKmlztL0

[The Lancet @TheLancet]

Read our latest issue in full ➡️ https://t.co/M1BE31WuMg

[Hayley Gershengorn @HBGMD]

🤯 As cancer treatment advances, ICU clinicians must stay up-to-date on caring for complications…

Just out in #journal_CHESTCritCare, @KMonty_MD, @DrGhanbar, et al explain how to manage immune checkpoint inhibitor pneumonitis in ICU: 💉🫁

https://t.co/cpH9mlEHb1

[Hayley Gershengorn @HBGMD]

💊 Tylenol to treat headaches & fevers… but sepsis? 🦠

Just out in #journal_CHESTCritCare, Obeidalla & colleagues provide compelling data suggesting further study is warranted:

https://t.co/KSdQvQYsBC

#OpenAccess

[Hayley Gershengorn @HBGMD]

☹️ Just as I was feeling sad that #CHEST2024 is coming to an end…

Walker, Yarnell, et al’s new study ?ing how race/ethnicity/sex associate w use of ICU sedation in #journal_CHESTCritCare (just out today) has made me 😃

https://t.co/vhpjw14p07

[Hayley Gershengorn @HBGMD]

🎂 Happy 1st birthday, #journal_CHESTCritCare!

As Vol 2, Iss 2 drops today, we are a year into our journey… 🚗

…& oh how we’ve grown!

⭐️ 16 original research articles
⭐️ 2 HIDIs/reviews
⭐️ 1 case series
⭐️ 6 editorials

👀 Check it out at:

https://t.co/hfSGW7nZuK

[John Reilly @John_P_Reilly]

@eemoin So true!

[Maryl Kreider MD MSCE @marylpennpulm]

So incredibly proud of #EnoEssien. Recent alumni and winner of ATS Bear Cage 2024 for her nanoparticles for ARDS therapy. Such impressive work and such an impressive woman. Keep an eye on her - she is going to go far! @PennPulmonary #ATS2024 @atscommunity

[Maryl Kreider MD MSCE @marylpennpulm]

Former chief fellow @R_M_Bennett presenting a latent class analysis that identified 2 endotypes of respiratory failure in sepsis. Such a great start to her research career! @PennPulmonary #ATS2024

[Maryl Kreider MD MSCE @marylpennpulm]

Such great support by @PennPulmonary fellows for fellows (and one faculty member @mpkerlin). Love the community! #ATS2024 @atscommunity

[Nuala Meyer @nualameyer]

#ATS2024 @ATSCritCare great discussions about improving sepsis and pneumonia trials and patient-oriented research at A23 “Investigating Heterogeniety” - host factors vs pathogen factors, ensuring trial representativeness @John_P_Reilly @KitsiosMd Dr. Claire Shappell

[Dr. Glaucomflecken @DGlaucomflecken]

I’m going to #ATS2024 tomorrow. I’m sitting here googling “do people say ARDSSS or A-R-D-S?” I’m too much of an ophthalmologist for this.

[ATS Early Career @atsearlycareer]

Congratulations to the 3 finalists of the BEAR Cage competition! Dr. Essien Dr. Huapaya and Dr. Milled!

Mark your calendars for May 20, 2024, from
1:30 - 3:30p.m. and cheer on our three finalists

📍Exhibit Hall G, Innovation Theater

#ATS2024 #MedEd #SharkTank